Search Results

SCAI Announces Publication of SAFE-MCS Study’s Design and Rationale

July 5, 2023—The Society for Cardiovascular Angiography and Interventions (SCAI) announced the publication of the design and rationale of the SAFE-MCS study by Philippe Généreux, MD, et al online in the JSCAI.

National Cardiogenic Shock Initiative Publishes Final Results

December 18, 2023—Henry Ford Health in Detroit, Michigan, recently announced the publication of final results from the National Cardiogenic Shock Initiative (NCSI), which was led by a cardiology research team based at Henry Ford Hospital.

Saranas Early Bird Bleed Monitoring System Evaluated in SAFE-MCS Study

March 11, 2024—Saranas, Inc. announced results of SAFE-MCS, a multicenter clinical study evaluating the safety of complex high-risk percutaneous coronary intervention (PCI) using mechanical circulatory support (MCS) and surveillance with the company’s Early Bird bleed monitoring system (EBBMS).

Saranas SAFE-MCS Trial of Early Bird Bleed Monitoring System Completes Enrollment

September 18, 2023—Saranas, Inc. announced that it has completed enrollment in the SAFE-MCS study evaluating the safety of complex high-risk percutaneous coronary intervention (PCI) using mechanical circulatory support (MCS) and surveillance with the company’s Early Bird bleed monitoring system.

Saranas Early Bird Bleed Monitoring System Evaluated in SAFE-MCS Trial of High-Risk PCI Using Mechanical Circulatory Support

December 6, 2021—Saranas, Inc. announced the initiation of the SAFE-MCS clinical trial evaluating the safety of complex high-risk percutaneous coronary intervention (PCI) using mechanical circulatory support (MCS) and surveillance with the company’s Early Bird bleed monitoring system.

Saranas’ SAFE-MCS Trial Reaches Enrollment Midpoint

March 27, 2023—Saranas, Inc. announced that it has reached the midpoint for enrollment in the SAFE-MCS clinical trial.

CERAMICS Registry Studies Mechanical Circulatory Support Escalation in Cardiogenic Shock

May 4, 2026—Findings from the CERAMICS registry demonstrated that early use of a mechanical circulatory support (MCS) improved outcomes in patients experiencing cardiogenic shock (CS) after experiencing a heart attack and undergoing a stenting procedure.

Zoll Medical’s TherOx SSO2 Therapy to Be Studied in ISO SHOCK IDE Trial

May 13, 2021—Zoll Medical Corporation, an Asahi Kasei company, announced that the FDA has approved an investigational device exemption (IDE) for a randomized prospective study evaluating the use of TherOx supersaturated oxygen (SSO2) therapy in patients presenting with ST-elevation myocardial infarction (STEMI) and cardiogenic shock and treated concurrently with a mechanical circulatory support device.

SCAI Presents Late-Breaking Studies of Treatment Protocols for Cardiogenic Shock Patients

April 28, 2021—The Society for Cardiovascular Angiography & Interventions (SCAI) announced that two new studies providing treatment insights for cardiogenic shock (CS) patients were presented as late-breaking clinical science at the SCAI 2021 Virtual Scientific Sessions.

Conscious Sedation Compared With General Anesthesia for TAVR

December 1, 2017—A study comparing conscious sedation versus general anesthesia for transcatheter aortic valve replacement (TAVR) was published by Matthew C. Hyman, MD, et al in Circulation (2017;136:2132–2140).